Showing results (2011-2020 of 8,257) with videos related to

Sort By:
Pageof 826
Haematologica|August 27, 2026
Response to Comment on: "Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasiarelated changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin"Dimitrios Kotsos, Jurjen Versluis
Haematologica|October 8, 2026
Preserving anthracycline-containing treatment in older patients with classical Hodgkin lymphoma: a role for liposomal doxorubicin. Comment on: "Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population"Claudia Giordano, Marco Picardi
Haematologica|October 8, 2026
Autoimmune and inflammatory diseases associated with T-cell clonal expansionCamille Frelicot, Thierry Lamy, Nicolas Chapuis, et al.
Haematologica|October 8, 2026
Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpressionSteven Hsu, Gisele O L Rodrigues, Nathan Wong, et al.
Haematologica|October 8, 2026
High incidence of venous thromboembolism after autologous stem cell transplantation in multiple myelomaCătălina Codreanu, Koen M Klomberg, Gerwin A Huls, et al.
Haematologica|October 15, 2026
Early measurement of ST2 and REG3α has a prognostic impact in haploidentical transplantation with post-transplant cyclophosphamideMarta Fonseca-Santos, María García-Álvarez, Luis Antonio Corchete Sánchez, et al.
Haematologica|October 15, 2026
The double-edged sword of Plasmodium falciparum: malaria and a predisposition to B-cell malignancy?Vaskar Saha
Haematologica|October 15, 2026
Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy"Xia Jiang, Ying Lu
Haematologica|October 15, 2026
Cord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expressionMakiko Suga, Shuhei Kida, Yo Mizutani, et al.
Haematologica|September 3, 2026
Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patientsIoannis Ntanasis-Stathopoulos, Panagiota-Efstathia Nikolaou, Charalampos Filippatos, et al.
Pageof 826